C84.71
Anaplastic large cell lymphoma, ALK-negative, lymph nodes of head, face, and neck
Clinical Classification Guidelines
Medical Intelligence & Overview
Anaplastic large cell lymphoma (ALCL) is a type of non-Hodgkin lymphoma that originates in T-cells, a kind of white blood cell. The specific category, ALK-negative ALCL, affects lymph nodes located in the head, face, and neck regions. This form differs from ALK-positive ALCL based on genetic features and may have different treatment responses and prognosis. Recognizing and understanding this condition is essential for affected individuals and their loved ones to navigate the diagnostic process and treatment options.
Causes & Symptoms
Clinical Causes: Genetic mutations that lead to abnormal T-cell growth Certain environmental factors may contribute, though specific causes are often unknown Potential links to previous infections or immune system dysregulation Rare familial genetic predispositions
Key Symptoms: Swelling or lumps in the neck, face, or head Persistent or painless swollen lymph nodes Unexplained weight loss Fever and chills Night sweats Fatigue or weakness Itching or skin rash over affected areas Difficulty swallowing or breathing if lymph nodes enlarge significantly
Diagnostic & Treatment
Diagnosis Path: Diagnosing ALK-negative ALCL involves a combination of medical evaluations and laboratory tests. Typically, the process includes:
Treatment Protocols: Treatment strategies for ALK-negative ALCL aim to eliminate cancer cells and manage symptoms. They usually involve a multidisciplinary approach, which may include:
Clinical Advice & FAQs
Billing Guidance
Is C84.71 a billable ICD-10 code?
Yes, C84.71 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.
Documentation
How do I report C84.71?
Clinical documentation must specify the nature of Anaplastic large cell lymphoma, ALK-negative, lymph nodes of head, face, and neck and any associated comorbidities for accurate reporting.
Cite this Clinical Reference